Regarding biological implications of CD8+HLA-DR+ cells, we observed that these Treg cells were present in TILs of patients with NSCLC at even higher frequencies than CD4+FOXP3+ Treg cells (5). The gene discussed is CD8A; the disease is non-small cell lung carcinoma.